Results 131 to 140 of about 7,822 (201)

A pilot study demonstrating the identification of Trypanosoma brucei gambiense and T. b. rhodesiense in vectors using a multiplexed high-resolution melt qPCR. [PDF]

PLoS Negl Trop Dis, 2020
Garrod G, Adams ER, Lingley JK, Saldanha I, Torr SJ, Cunningham LJ.   +5 more
europepmc   +1 more source

Melarsoprol-Free Drug Combinations for Second-Stage Gambian Sleeping Sickness: The Way to Go. [PDF]

, 2007
Balasegaram, Brun, F. Chappuis, Priotto, P  pin, P  pin, Van Nieuwenhove   +6 more
core   +2 more sources

Unusual MRI Findings in African Trypanosoma brucei gambiense Trypanosomiasis: Dentate Nuclei and Hypothalamic Lesions. [PDF]

Am J Trop Med Hyg, 2020
Boukobza M, Lariven S, Houzé S, Laissy JP.   +3 more
europepmc   +1 more source

Isolation and propagation of Trypanosoma brucei gambiense from sleeping sickness patients in south Sudan [PDF]

, 2017
This study aimed at isolating Trypanosoma brucei gambiense from human African trypanosomiasis (HAT) patients from south Sudan. Fifty HAT patients identified during active screening surveys were recruited, most of whom (49/50) were in second-stage disease.
Brun, Reto, Kunz, Christina, Maeser, Pascal, Maina, Naomi W.N., Ndung'u, Joseph M., Oberle, Michael, Otieno, Charles   +6 more
core  

Gènes d'antigènes variables chez Trypanosoma brucei gambiense

, 1989
Doctorat en ...
openaire   +1 more source

Molecular identification of Trypanosoma brucei gambiense in naturally infected pigs, dogs and small ruminants confirms domestic animals as potential reservoirs for sleeping sickness in Chad. [PDF]

Parasite, 2020
Vourchakbé J, Tiofack ZAA, Kante TS, Mpoame M, Simo G.   +4 more
europepmc   +1 more source

The detection and treatment of human African trypanosomiasis

Research and Reports in Tropical Medicine, 2012
Bernard Bouteille,1 Alain Buguet21Laboratory of Parasitology, Dupuytren University Hospital of Limoges, France; 2Polyclinic Marie-Louise Poto-Djembo, Pointe-Noire, CongoAbstract: Human African trypanosomiasis (HAT) is caused by the injection of ...
Bouteille B, Buguet A
doaj  

Oral fexinidazole for stage 1 or early stage 2 African Trypanosoma brucei gambiense trypanosomiasis: a prospective, multicentre, open-label, cohort study.

Lancet Glob Health, 2021
Kande Betu Ku Mesu V, Mutombo Kalonji W, Bardonneau C, Valverde Mordt O, Ngolo Tete D, Blesson S, Simon F, Delhomme S, Bernhard S, Mahenzi Mbembo H, Mpia Moke C, Lumeya Vuvu S, Mudji E'kitiak J, Akwaso Masa F, Mukendi Ilunga M, Mpoyi Muamba Nzambi D, Mayala Malu T, Kapongo Tshilumbwa S, Botalema Bolengi F, Nkieri Matsho M, Lumbala C, Scherrer B, Strub-Wourgaft N, Tarral A.   +23 more
europepmc   +1 more source

Trypanosoma brucei gambiense group 2 experimental in vivo life cycle: from procyclic to bloodstream form. [PDF]

Parasite
Juban P, Bart JM, Ségard A, Jamonneau V, Ravel S.   +4 more
europepmc   +1 more source

The elimination of Trypanosoma brucei gambiense? Challenges of reservoir hosts and transmission cycles: Expect the unexpected. [PDF]

Parasite Epidemiol Control, 2019
Mehlitz D, Molyneux DH.
europepmc   +1 more source